Articles by Marsha A. Raebel, PharmD
Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting
ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Lawrence D. Garber, MD,Jennifer L. Donovan, PharmD,Abir O. Kanaan, PharmD,Marsha A. Raebel, PharmD,Yanfang Zhao, MA,Jacquelyne C. Fuller, MPH,Shawn J. Gagne, BA,Shira H. Fischer, AB,Jerry H. Gurwitz, MD Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.
This article summarizes the outcomes from a pilot online curriculum on off-label prescribing, appraising pharmaceutical information, and talking with patients about advertised medications.
Improving Laboratory Monitoring of Medications: An Economic Analysis Alongside a Clinical Trial
ByDavid H. Smith, RPh, PhD,Adrianne C. Feldstein, MD,Nancy A. Perrin, PhD,Xiuhai Yang, MS,Mary M. Rix, RN,Marsha A. Raebel, PharmD,David J. Magid, MD,Steven R. Simon, MD,Stephen B. Soumerai, ScD Although some interventions may enhance medication safety, an electronic medical record reminder to providers may not be an efficient use of resources.
Monitoring of Drugs With a Narrow Therapeutic Range in Ambulatory Care
ByMarsha A. Raebel, PharmD,Nikki M. Carroll, MS,Susan E. Andrade, ScD,Elizabeth A. Chester, PharmD,Jennifer Elston Lafata, PhD,Adrianne Feldstein, MD,Margaret J. Gunter, PhD,Winnie W. Nelson, PharmD,Steven R. Simon, MD, MPH,K. Arnold Chan, MD, ScD,Robert L. Davis, MD, MPH,Richard Platt, MD The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) Study: Evaluating the Role of Drug Therapy Within a Weight Management Program in a Group-Model Health Maintenance Organizati
ByJulie A. Porter, PharmD,Marsha A. Raebel, PharmD,Douglas A. Conner, PhD,Frances A. Lanty, PharmD,Erin A. Vogel, PharmD,Elizabeth C. Gay, MA,John A. Merenich, MD